Table 5 Frequency of the “confirmed non-OI” and “possible/patient and pathogen-related OI” adjudicated by the SAC
HLT-PT name N(%) | “Confirmed non-OI” N = 59 (%) | “Possible/patient and pathogen-related OI” N = 299 (%) |
|---|---|---|
Herpes viral infections,N = 193 (64.5) | ||
Varicella | 128 (42.8) | |
Oral herpes | 30 (10.1) | |
Varicella zoster virus infection | 24 (8.1) | |
Other herpes infections | 11 (3.7) | |
Epstein-Barr viral infections,N = 38 (12.7) | ||
Epstein-Barr virus infection | 22 (7.4) | |
Other EBV infections | 16 (5.3) | |
Tuberculous infections,N = 18 (6.0) | ||
Latent tuberculosis | 12 (4.1) | |
Tuberculosis | 6 (2.0) | |
Candidainfections,N = 8 (2.7) | ||
Vulvovaginal candidiasis | 6 (2.1) | |
Other candidiasis | 2 (0.6) | |
Influenza viral infections,N = 14 (23.7) | ||
Influenza | 13 (22) | |
H1N1 influenza | 1 (1.7) | |
Streptococcal infections,N = 14 (23.7) | ||
Scarlet fever | 4 (6.7) | |
Pharyngitis streptococcal | 3 (5.1) | |
Other streptococcal infections | 7 (11.9) | |
Salmonellainfections,N = 9 (3.0) | ||
Gastroenteritis salmonella | 6 (2.1) | |
Other Salmonella infections | 3 (1.0) | |
Molluscum contagiosum viral infections,N = 7(2.3) (2.3) | ||
Molluscum contagiosum | 7 (2.3) | |
Staphylococcal infections,N = 5 (8.5) | ||
Staphylococcal sepsis | 2 (3.4) | |
Other staphylococcal infections | 3 (5.1) | |
Escherichia infections,N = 4 (6.8) | ||
Escherichia pyelonephritis | 3 (5.1) | |
Cystitis Escherichia | 1 (1.7) | |
Skin structures and soft tissue infections,N = 3 (5.1) (5.1) | ||
Impetigo | 3 (5.1) | |
Bordetella infections, N = 3 (5.1) | ||
Pertussis | 2 (3.4) | |
Bordetella infection | 1 (1.7) | |
Mycoplasma infections, N = 3 (5.1) | ||
Mycoplasma infections | 3 (5.1) | |
Yersinia infections, N = 2 (3.4) | ||
Gastroenteritis yersinia | 2 (3.4) | |
Other infections (HLT frequency < 2%) | 11 (18.6) | 26 (8.7) |